Loading clinical trials...
Loading clinical trials...
To investigate dose-response efficacy and safety in hemodialysis patients with hyperphosphatemia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
NCT06978127 · Chronic Kidney Disease Requiring Hemodialysis
NCT06660277 · Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD), and more
NCT06960304 · Chronic Kidney Disease Requiring Hemodialysis
NCT06771973 · End Stage Renal Disease (ESRD), Chronic Kidney Disease Requiring Hemodialysis
Japan
Multiple Locations
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions